Science Explorer Back to mapMap
Discussion
Topic · Nephrology

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes is a research topic within Nephrology. Science Explorer counts 37k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on chronic kidney disease (CKD) and its various aspects including estimation of glomerular filtration rate, association with cardiovascular disease, diabetic nephropathy, renal insufficiency, albuminuria, fibrosis, TGF-ß signaling, and the global burden of CKD. It covers topics related to diagnosis, management, risk factors, and implications of CKD on mortality and cardiovascular outcomes.

  • Chronic Kidney Disease
  • Glomerular Filtration Rate
  • Cardiovascular Disease
  • Diabetic Nephropathy
  • Renal Insufficiency
  • Albuminuria
  • Fibrosis
  • TGF-ß
  • Obesity-related Glomerulopathy
  • Global Burden
Research works
37k
fractional, since 1950
In the world top 10%
3.6k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+37%
the tick is no change
Largest producer
China
41% of the 10 largest, 2022-now
Chronic Kidney Disease and Diabetes

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Chronic Kidney Disease and Diabetes research?

By volume, China and the United States publish the most (3k and 1.7k works in 2022-now).

By volume, 2022-now

  1. 1 China 3k works
  2. 2 United States 1.7k works
  3. 3 Japan 554 works
  4. 4 India 492 works
  5. 5 United Kingdom 364 works
  6. 6 South Korea 311 works
  7. 7 Germany 257 works
  8. 8 Italy 232 works
  9. 9 Australia 205 works
  10. 10 Spain 205 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 41.1%United States: 23.3%Japan: 7.5%India: 6.7%6 others listed: 21.4%41%largest
China3,021 · 41.1%United States1,715 · 23.3%Japan554 · 7.5%India492 · 6.7%6 others listed1,574 · 21.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Chronic Kidney Disease and Diabetes research?

By volume in 2022-now, Nanjing Medical University publishes the most Chronic Kidney Disease and Diabetes research, followed by Sichuan University and Peking University.

By volume, 2022-now

  1. 1 Nanjing Medical UniversityChina 76 works
  2. 2 Sichuan UniversityChina 76 works
  3. 3 Peking UniversityChina 74 works
  4. 4 Harvard UniversityUnited States 73 works
  5. 5 Sun Yat-sen UniversityChina 69 works
  6. 6 Capital Medical UniversityChina 69 works
  7. 7 Shanghai Jiao Tong UniversityChina 67 works
  8. 8 Southern Medical UniversityChina 64 works
  9. 9 Central South UniversityChina 57 works
  10. 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 55 works

Who are the leading researchers in Chronic Kidney Disease and Diabetes?

The most-cited researchers publishing on Chronic Kidney Disease and Diabetes include Christopher J L Murray, Freddie Bray and Simon Iain Hay.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Simon Iain Hay United States 452k citations
  4. 4 Theo Vos United States 439k citations
  5. 5 George Davey Smith United Kingdom 435k citations
  6. 6 Ali H. Mokdad United States 429k citations
  7. 7 Walter Churchill Willett United States 411k citations
  8. 8 Jost Bruno Jonas Germany 350k citations
  9. 9 John J.V. McMurray United Kingdom 349k citations
  10. 10 Hermann Brenner Germany 343k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Chronic Kidney Disease and Diabetes?

The most cited paper in Chronic Kidney Disease and Diabetes is "A New Equation to Estimate Glomerular Filtration Rate" (Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al., 2009), with 26,119 citations. Next come "A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation" (15,196) and "Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization" (11,467).

Most cited papers
#PaperReleasedCitations
1 A New Equation to Estimate Glomerular Filtration Rate Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine Open access 5 May 2009 26,119
2 A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Andrew S. Levey, Juan P. Bosch, Julia Breyer Lewis et al. · Annals of Internal Medicine 16 Mar 1999 15,196
3 Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization Alan S. Go, Glenn Matthew Chertow, Dongjie Fan et al. · New England Journal of Medicine Open access 22 Sep 2004 11,467
4 KDIGO Clinical Practice Guidelines for Acute Kidney Injury Arif Khwaja · Nephron Clinical Practice 7 Aug 2012 8,233
5 Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy Barry Morton Brenner, Mark Emmanuel Cooper, Dick de Zeeuw et al. · New England Journal of Medicine Open access 20 Sep 2001 7,554
All 100 most cited papers, with filters and sorting

Where is Chronic Kidney Disease and Diabetes research done?

The largest centres of Chronic Kidney Disease and Diabetes research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Luzhou.

Largest cities, 2022-now

  1. 1 BeijingChina 380 works
  2. 2 GuangzhouChina 235 works
  3. 3 ShanghaiChina 215 works
  4. 4 SeoulSouth Korea 174 works
  5. 5 TokyoJapan 157 works
  6. 6 NanjingChina 139 works
  7. 7 ChengduChina 131 works
  8. 8 WuhanChina 114 works
  9. 9 HangzhouChina 112 works
  10. 10 LondonUnited Kingdom 100 works

Where it is the local speciality

  1. LuzhouCN · 21.0 works8.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Chronic Kidney Disease and Diabetes than the world average.

See Chronic Kidney Disease and Diabetes on the map

Where is the best place to study Chronic Kidney Disease and Diabetes?

Among universities, judged by research, Harvard University, Southern Medical University and Central South University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 16.31%fractional works in this field (log) →share of work in the world top 10% →Wuhan UniversityCentral South Univer…Southern Medical Uni…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 83.015.8%2.5×73 +36.5%
2Southern Medical UniversityChina 77.517.7%11.4×64 +64.4%
3Central South UniversityChina 73.719.4%3.3×57 +34.8%
4Wuhan UniversityChina 72.226.0%2.7×35 +107.4%
5Sichuan UniversityChina 70.915.0%3.7×76 +85.0%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 70.316.6%5.8×55 +129.9%
7Johns Hopkins UniversityUnited States 69.613.6%3.3×46 +2.6%
8Peking UniversityChina 69.313.0%4.0×74 +56.2%
9Capital Medical UniversityChina 69.314.1%7.1×69 +128.5%
10Nanjing Medical UniversityChina 68.711.9%9.4×76 +79.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Chronic Kidney Disease and Diabetes, country by country

Is Chronic Kidney Disease and Diabetes research growing?

Output in 2022-2025 was 37% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Chronic Kidney Disease and Diabetes.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Chronic Kidney Disease and Diabetes as a percentage of every work published that year, 0.036% in 2024.

still counting0.020%0.040%0.060%Chronic Kidney Disease and Diabetes0.049% in 202519801990200020102020

Fractional works of Chronic Kidney Disease and Diabetes over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Chronic Kidney Disease and Diabetes9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who is researching a cure for chronic kidney disease?

By volume in 2022-now, Nanjing Medical University publishes the most Chronic Kidney Disease and Diabetes research, followed by Sichuan University and Peking University. By volume, China and the United States publish the most (3k and 1.7k works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Chronic Kidney Disease and Diabetes. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.